Your Article Summary
BioSante Pharmaceuticals and Cell Genesys Announce Approval of Merger by BioSante Stockholders and Adjournment of Cell Genesys Stockholders Meeting Until October 2009
Cell Genesys, 10/01/09
BioSante Pharmaceuticals, Inc. and Cell Genesys, Inc., announced that BioSante stockholders have approved the merger between the two companies with BioSante as the surviving company.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor


See Latest Articles


